The use of clozapine in adults with intellectual disability
- 11 August 2004
- journal article
- Published by Wiley in Journal of Intellectual Disability Research
- Vol. 48 (6) , 572-579
Abstract
Background There are not many studies on the use of clozapine in patients with intellectual disability (ID). The authors describe a case series of patients treated with clozapine, drawn from a medium secure unit, a low secure assessment and treatment service and a community team in the London region.Method A retrospective file‐review of patients treated in these three settings during the time period March–June 2002 was performed (n = 24). Information was collected using a semistructured proforma.Results Of the 24 patients, 67% had schizophrenia, 17% had schizoaffective disorder and 8% had bipolar disorder. Patients had been unwell for a mean of 6 years and had been tried on a mean of four antipsychotics. The mean maximum dose of clozapine was 488 mg. The outcomes on the clinical global impression (CGI) scale showed 29% very much improved, 42% much improved, 21% minimally improved and 8% no change. 54% of the whole sample and 53% of those from the medium secure unit were discharged to homes in the community. The drug had to be stopped in four patients, of which three were because of neutropaenia.Conclusion Clozapine appears to be safe and efficacious in many people with ID. Careful monitoring of side‐effects is needed during therapy.Keywords
This publication has 30 references indexed in Scilit:
- Atypical antipsychotics in persons with developmental disabilitiesMental Retardation and Developmental Disabilities Research Reviews, 1999
- Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF)The British Journal of Psychiatry, 1998
- Primary Health Care for People with a Learning DisabilityBritish Journal of Learning Disabilities, 1996
- Model for reduced brain dopamine in Lesch‐Nyhan syndrome and the mentally retarded: Neurobiology of neonatal‐6‐hydroxydopamine‐lesioned ratsMental Retardation and Developmental Disabilities Research Reviews, 1995
- Clinical trials of D1 and D2 dopamine modulating drugs and self‐injury in mental retardation and developmental disabilityMental Retardation and Developmental Disabilities Research Reviews, 1995
- Epilepsy.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Clozapine - Beneficial and Untoward Effects: An UpdatePharmacopsychiatry, 1992
- Psychosis in Mental HandicapThe British Journal of Psychiatry, 1977
- Tardive Dyskinesia as a Possible Sequel of Long-Term Therapy with PhenothiazinesClinical Pediatrics, 1975
- The Treatment of Behavior Disorders in Idiocy and Imbecility with ClozapinePharmacopsychiatry, 1974